牙周病在非酒精性脂肪性肝病中的作用及机制研究进展
收稿日期: 2022-07-05
网络出版日期: 2023-05-15
基金资助
上海市科技计划项目(20ZR1431900);口腔疾病研究国家重点实验室开放课题(SKLOD2022OF01)
Advances in research on effect of periodontitis on non-alcoholic fatty liver disease and mechanism
段中华, 王宇华, 郭斯敏 . 牙周病在非酒精性脂肪性肝病中的作用及机制研究进展[J]. 内科理论与实践, 2023 , 18(02) : 107 -110 . DOI: 10.16138/j.1673-6087.2023.02.009
| [1] | Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64(1): 73-84. |
| [2] | Younossi ZM, Otgonsuren M, Henry L, et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009[J]. Hepatology, 2015, 62(6): 1723-1730. |
| [3] | Holt SC, Ebersole JL. Porphyromonas gingivalis, treponema denticola, and tannerella forsythia: the“red complex”, a prototype polybacterial pathogenic consortium in periodontitis[J]. Periodontol, 2005, 38: 72-122. |
| [4] | Furuta M, Ekuni D, Yamamoto T, et al. Relationship between periodontitis and hepatic abnormalities in young adults[J]. Acta Odontologica Scandinavica, 2010, 68(1): 27-33. |
| [5] | Kim JY, Lee GN, Song HC, et al. Association between fatty liver index and periodontitis: the Korea National Health and Nutrition Examination Survey[J]. Sci Rep, 2020, 10(1): 3805. |
| [6] | Kuroe K, Furuta M, Takeuchi K, et al. Association between periodontitis and fibrotic progression of non-alcoholic fatty liver among Japanese adults[J]. J Clin Periodontol, 2021, 48(3): 368-377. |
| [7] | Akinkugbe AA, Slade GD, Barritt AS, et al. Periodontitis and non-alcoholic fatty liver disease, a population-based cohort investigation in the Study of Health in Pomerania[J]. J Clin Periodontol, 2017, 44(11): 1077-1087. |
| [8] | 杜芹, 马歆茹. 牙周致病菌与系统性疾病的相关性研究进展[J]. 南方医科大学学报, 2020, 40(5): 759-764. |
| [9] | Yoneda M, Naka S, Nakano K, et al. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease[J]. BMC Gastroenterol, 2012, 12: 16. |
| [10] | Nakahara T, Hyogo H, Ono A, et al. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease[J]. J Gastroenterol, 2018, 53(2): 269-280. |
| [11] | Furusho H, Miyauchi M, Hyogo H, et al. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice[J]. J Gastroenterol, 2013, 48(11): 1259-1270. |
| [12] | Kuraji R, Ito H, Fujita M, et al. Porphyromonas gingivalis induced periodontitis exacerbates progression of non-alcoholic steatohepatitis in rats[J]. Clin Exp Dent Res, 2016, 2(3): 216-225. |
| [13] | 杜留熠, 孙晓琳, 于维先, 等. 牙龈卟啉单胞菌菌毛致病机制的研究进展[J]. 中华口腔医学杂志, 2018, 53(10): 703-707. |
| [14] | Nakano K, Inaba H, Nomura R, et al. Distribution of Porphyromonas gingivalis fimA genotypes in cardiovascular specimens from Japanese patients[J]. Oral Microbiol Immunol, 2008, 23(2): 170-172. |
| [15] | Arimatsu K, Yamada H, Miyazawa H, et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota[J]. Sci Rep, 2014, 4: 4828. |
| [16] | Nakajima M, Arimatsu K, Kato T, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver[J]. PLoS One, 2015, 10(7): e0134234. |
| [17] | Yamazaki K, Kato T, Tsuboi Y, et al. Oral pathobiont-induced changes in gut microbiota aggravate the pathology of nonalcoholic fatty liver disease in mice[J]. Front Immunol, 2021, 12: 766170. |
| [18] | Armingohar Z, J?rgensen JJ, Kristoffersen AK, et al. Bacteria and bacterial DNA in atherosclerotic plaque and aneurysmal wall biopsies from patients with and without periodontitis[J]. J Oral Microbiol, 2014, 6(1): 3402. |
| [19] | Geerts SO, Nys M, De MP, et al. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity[J]. J Periodontol, 2002, 73(1): 73-78. |
| [20] | Wahaidi VY, Kowolik MJ, Eckert GJ, et al. Endotoxemia and the host systemic response during experimental gingivitis[J]. J Clin Periodontol, 2011, 38(5): 412-417. |
| [21] | Sasaki N, Katagiri S, Komazaki R, et al. Endotoxemia by porphyromonas gingivalis injection aggravates non-alcoholic fatty liver disease, disrupts glucose/lipid metabolism, and alters gut microbiota in mice[J]. Front Microbiol, 2018, 9: 2470. |
| [22] | 张冬霞, 林江. 中性粒细胞在牙周炎和糖尿病双向关系中作用的研究进展[J]. 医学综述, 2019, 25(17): 3338-3343. |
| [23] | 邹慧琼, 刘雅芳, 周家敏, 等. 牙周非手术治疗对慢性牙周炎患者循环CD34+/CD309+/CD45-内皮祖细胞和氧化三甲胺的影响[J]. 临床口腔医学杂志, 2022, 38(2): 82-86. |
| [24] | Méndez-Sánchez N, Valencia-Rodríguez A, Coronel-Castillo C, et al. The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis[J]. Ann Transl Med, 2020, 8(6): 400. |
| [25] | Yu S, Ding L, Liang D, et al. Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing α-ketoglutarate production in mice[J]. Mol Oral Microbiol, 2018, 33(5): 388-395. |
| [26] | 周玲. 牙龈卟啉单胞菌脂多糖对骨质疏松大鼠骨髓巨噬细胞生物学行为的影响[D]. 福州: 福建医科大学, 2019. |
| [27] | Han YH, Kim HJ, Na H, et al. RORα induces KLF4-mediated M2 polarization in the liver macrophages that protect against nonalcoholic steatohepatitis[J]. Cell Reports, 2017, 20(1):124-135. |
| [28] | Neufeld-Cohen A, Robles MS, Aviram R, et al. Circadian control of oscillations in mitochondrial rate-limiting enzymes and nutrient utilization by PERIOD proteins[J]. Proc Natl Acad Sci U S A, 2016, 113(12): E1673-E1682. |
| [29] | Gooley JJ. Circadian regulation of lipid metabolism[J]. Proc Nutr Soc, 2016, 75(4): 440-450. |
/
| 〈 |
|
〉 |
